Manchester Management | GenomeWeb

Manchester Management

Manchester Management's James Besser this week sent a letter to the company's board and shareholders asserting that management had moved the date of Vermillion's annual meeting to make difficult any action by shareholders dissatisfied by the poor performance of the firm's stock.

An exchange this week between Vermillion and the Boston-based hedge fund that holds a nearly 10 percent stake in the company has exposed a rift between the company's management and one of its largest shareholders.

The shareholder wants to make it easier to make changes to Vermillion's management team and board amid a drop in the company's share price over the past year.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.